The University of Chicago Header Logo

Connection

Anita S. Chong to Lymphocyte Activation

This is a "connection" page, showing publications Anita S. Chong has written about Lymphocyte Activation.
Connection Strength

2.361
  1. Evolving Approaches in the Identification of Allograft-Reactive T and B Cells in Mice and Humans. Transplantation. 2017 11; 101(11):2671-2681.
    View in: PubMed
    Score: 0.504
  2. Tracing Donor-MHC Class II Reactive B cells in Mouse Cardiac Transplantation: Delayed CTLA4-Ig Treatment Prevents Memory Alloreactive B-Cell Generation. Transplantation. 2016 08; 100(8):1683-91.
    View in: PubMed
    Score: 0.462
  3. Alloantibodies prevent the induction of transplantation tolerance by enhancing alloreactive T cell priming. J Immunol. 2011 Jan 01; 186(1):214-21.
    View in: PubMed
    Score: 0.312
  4. The immunosuppressive metabolite of leflunomide, A77 1726, affects murine T cells through two biochemical mechanisms. J Immunol. 1997 Jul 01; 159(1):22-7.
    View in: PubMed
    Score: 0.123
  5. Transplantation tolerance: don't forget about the B cells. Clin Exp Immunol. 2017 08; 189(2):171-180.
    View in: PubMed
    Score: 0.120
  6. Delayed Cytotoxic T Lymphocyte-Associated Protein 4-Immunoglobulin Treatment Reverses Ongoing Alloantibody Responses and Rescues Allografts From Acute Rejection. Am J Transplant. 2016 08; 16(8):2312-23.
    View in: PubMed
    Score: 0.113
  7. ICAM-1 and LFA-3 enhance the ability of anti-CD3 mAb to stimulate interferon gamma production in interleukin-2-activated T cells. Cancer Immunol Immunother. 1994 Aug; 39(2):127-34.
    View in: PubMed
    Score: 0.101
  8. Transplantation tolerance and its outcome during infections and inflammation. Immunol Rev. 2014 Mar; 258(1):80-101.
    View in: PubMed
    Score: 0.098
  9. Leflunomide, a novel immunosuppressive agent. The mechanism of inhibition of T cell proliferation. Transplantation. 1993 Jun; 55(6):1361-6.
    View in: PubMed
    Score: 0.093
  10. Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor. J Immunol. 1989 Mar 15; 142(6):2133-9.
    View in: PubMed
    Score: 0.069
  11. Memory alloreactive B cells and alloantibodies prevent anti-CD154-mediated allograft acceptance. J Immunol. 2009 Feb 01; 182(3):1314-24.
    View in: PubMed
    Score: 0.069
  12. Cutting edge: Cbl-b: one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation. J Immunol. 2004 Dec 15; 173(12):7135-9.
    View in: PubMed
    Score: 0.052
  13. In vitro and in vivo mechanisms of action of the antiproliferative and immunosuppressive agent, brequinar sodium. J Immunol. 1998 Jan 15; 160(2):846-53.
    View in: PubMed
    Score: 0.032
  14. Self-Antigen-Driven Thymic B Cell Class Switching Promotes T Cell Central Tolerance. Cell Rep. 2016 10 04; 17(2):387-398.
    View in: PubMed
    Score: 0.029
  15. Adoptive Transfer of Tracer-Alloreactive CD4+ T Cell Receptor Transgenic T Cells Alters the Endogenous Immune Response to an Allograft. Am J Transplant. 2016 10; 16(10):2842-2853.
    View in: PubMed
    Score: 0.028
  16. Tracking of TCR-Transgenic T Cells Reveals That Multiple Mechanisms Maintain Cardiac Transplant Tolerance in Mice. Am J Transplant. 2016 10; 16(10):2854-2864.
    View in: PubMed
    Score: 0.028
  17. High-Fat Diet-Induced Obesity Enhances Allograft Rejection. Transplantation. 2016 05; 100(5):1015-21.
    View in: PubMed
    Score: 0.028
  18. Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4. Immunity. 2013 May 23; 38(5):918-29.
    View in: PubMed
    Score: 0.023
  19. Leflunomide, a novel immunomodulatory agent: in vitro analyses of the mechanism of immunosuppression. Transplant Proc. 1993 Feb; 25(1 Pt 1):747-9.
    View in: PubMed
    Score: 0.023
  20. Phenotypic and functional analysis of lymphokine-activated killer (LAK) cell clones. Ability of CD3+, LAK cell clones to produce interferon-gamma and tumor necrosis factor upon stimulation with tumor targets. Cancer Immunol Immunother. 1989; 29(4):270-8.
    View in: PubMed
    Score: 0.017
  21. Blocking of lymphokine activated killer (LAK) cell mediated cytotoxicity by cell-sized beads bearing tumor cell proteins. J Immunol. 1988 Dec 15; 141(12):4418-24.
    View in: PubMed
    Score: 0.017
  22. Inhibition of JAK3 and STAT6 tyrosine phosphorylation by the immunosuppressive drug leflunomide leads to a block in IgG1 production. J Immunol. 1998 Feb 15; 160(4):1581-8.
    View in: PubMed
    Score: 0.008
  23. Regulation of B cell function by the immunosuppressive agent leflunomide. Transplantation. 1996 Feb 27; 61(4):635-42.
    View in: PubMed
    Score: 0.007
  24. T cell immunodeficiency in dyskeratosis congenita. Arch Dis Child. 1992 Apr; 67(4):524-6.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.